全文获取类型
收费全文 | 645篇 |
免费 | 56篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 28篇 |
妇产科学 | 3篇 |
基础医学 | 96篇 |
口腔科学 | 10篇 |
临床医学 | 184篇 |
内科学 | 144篇 |
皮肤病学 | 5篇 |
神经病学 | 13篇 |
特种医学 | 16篇 |
外科学 | 56篇 |
综合类 | 2篇 |
一般理论 | 2篇 |
预防医学 | 48篇 |
眼科学 | 4篇 |
药学 | 43篇 |
肿瘤学 | 45篇 |
出版年
2022年 | 7篇 |
2021年 | 9篇 |
2019年 | 4篇 |
2018年 | 10篇 |
2017年 | 10篇 |
2016年 | 8篇 |
2015年 | 14篇 |
2014年 | 14篇 |
2013年 | 19篇 |
2012年 | 36篇 |
2011年 | 31篇 |
2010年 | 24篇 |
2009年 | 25篇 |
2008年 | 38篇 |
2007年 | 37篇 |
2006年 | 45篇 |
2005年 | 42篇 |
2004年 | 33篇 |
2003年 | 38篇 |
2002年 | 24篇 |
2001年 | 22篇 |
2000年 | 36篇 |
1999年 | 16篇 |
1998年 | 7篇 |
1997年 | 7篇 |
1996年 | 6篇 |
1995年 | 4篇 |
1994年 | 4篇 |
1993年 | 2篇 |
1992年 | 14篇 |
1991年 | 9篇 |
1990年 | 7篇 |
1989年 | 11篇 |
1988年 | 3篇 |
1987年 | 11篇 |
1986年 | 6篇 |
1985年 | 10篇 |
1984年 | 3篇 |
1983年 | 8篇 |
1982年 | 7篇 |
1981年 | 2篇 |
1980年 | 3篇 |
1979年 | 5篇 |
1978年 | 4篇 |
1977年 | 3篇 |
1975年 | 3篇 |
1974年 | 4篇 |
1973年 | 4篇 |
1972年 | 3篇 |
1971年 | 2篇 |
排序方式: 共有702条查询结果,搜索用时 31 毫秒
1.
Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care.
R Erbes K Oettel M Raffenberg H Mauch M Schmidt-Ioanas H Lode 《The European respiratory journal》2006,27(6):1223-1228
Severe tuberculosis (TB) requiring intensive care unit (ICU) care is rare but commonly known to be of markedly bad prognosis. The present study aimed to describe this condition and to determine the mortality rate and risk factors associated with mortality. Patients with confirmed TB admitted to ICU between 1990 and 2001 were retrospectively identified and enrolled. Clinical, radiological and bacteriological data at admission and during hospital stay were recorded. A multivariate analysis was performed to identify the predictive factors for mortality. A total of 58 TB patients (12 females, mean age 48 yrs) admitted to ICU were included. Mean Acute Physiology and Chronic Health Evaluation (APACHE) II score at admission was 13.1+/-5.6 and 22 of 58 (37.9%) patients required mechanical ventilation. The in-hospital mortality was 15 of 58 (25.9%); 13 (22.4%) patients died in the ICU. The mean survival of patients who died was 53.6 days (range 1-229), with 50% of the patients dying within the first 32 days. The factors independently associated with mortality were: acute renal failure, need for mechanical ventilation, chronic pancreatitis, sepsis, acute respiratory distress syndrome, and nosocomial pneumonia. These data indicate a high mortality of patients with tuberculosis requiring intensive care unit care and identifies new independently associated risk factors. 相似文献
2.
An elderly female alcohol and benzodiazepine addict presented with an atypical amnestic episode. Five days later she showed several complex partial seizures as main signs of a withdrawal state. The value of the EEG in the differential diagnosis of amnestic syndromes is emphasized. Temporolimbic involvement in withdrawal states is discussed and our ignorance regarding drug dependence and withdrawal in the elderly is stressed. It is suggested that late-onset partial seizures with unknown etiology in the elderly might be more often related to drug dependence than generally accepted. 相似文献
3.
4.
5.
Recurrent "Flexispira rappini" bacteremia in an adult patient undergoing hemodialysis: case report 下载免费PDF全文
Sorlin P Vandamme P Nortier J Hoste B Rossi C Pavlof S Struelens MJ 《Journal of clinical microbiology》1999,37(5):1319-1323
A blood culture from a 65-year-old febrile man undergoing hemodialysis revealed, 5 days after inoculation, an unusual gram-negative fusiform rod with darting motility. During another episode of fever 21 days later, this Campylobacter-like organism was again recovered from three blood cultures and subcultured under an H2-enriched microaerobic atmosphere. The organism was catalase negative and oxidase positive and hydrolyzed urea rapidly. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of whole-cell proteins was indistinguishable from that of "Flexispira rappini" LMG 8738 described by Archer et al. in 1988 (J. R. Archer, S. Romero, A. E. Ritchier, M. E. Hamacher, B. M. Steiner, J. H. Bryner, and R. F. Schell, J. Clin. Microbiol. 26:101-105, 1988). The analysis of the 16S ribosomal DNA sequence revealed a similarity of 99.3% between the two strains. The patient recovered completely after a 4-week course of meropenem therapy. This is the first reported case of a recurrent "F. rappini" bacteremia in an adult patient, which confirms that this organism may be an invasive pathogen in immunocompromised patients, like other newly described Helicobacter species. 相似文献
6.
Targeting of cytokines into the tumor microenvironment using antibody-cytokine fusion proteins, called immunocytokines, represents
a novel approach in cancer immunotherapy. This article summarizes therapeutic efficacy and immune mechanisms involved in targeting
interleukin-2 (IL-2) to neuroectodermal, tumors using ganglioside GD2-specific antibody-IL-2 fusion protein (ch14.18-IL-2).
Treatment of established melanoma metastases with ch14.18-IL-2 resulted in eradication of disease followed by a vaccination
effect protecting mice from lethal challenges, with wild-type tumor calls. In a syngeneic neuroblastoma model, targeted IL-2
was effective in the amplification of a weak memory immune response previously induced by IL-12 gene therapy using an engineered
linear version of this heterodimeric cytokine. These findings show that targeted IL-2 may provide an effective tool in cancer
immunotherapy and establish the missing link between T cell-mediated, vaccination and objective clinical responses. 相似文献
7.
8.
M. W. R. Pletz L. McGee O. Burkhardt H. Lode K. P. Klugman 《European journal of clinical microbiology & infectious diseases》2005,24(1):58-60
Reported here is the case of a patient with underlying chronic obstructive pulmonary disease (COPD) in whom ciprofloxacin treatment of a lower respiratory tract infection failed subsequent to ciprofloxacin treatment of an exacerbation of COPD several weeks earlier. During the second course of ciprofloxacin therapy, the patients condition continued to deteriorate, and she was admitted to the intensive care unit. Bilateral pneumonia was diagnosed. Streptococcus pneumoniae, serotype 11A, resistant to ciprofloxacin was isolated from the sputum. Sequencing revealed a S79F mutation in parC and there was evidence of an efflux pump. The patient improved rapidly after administration of azithromycin and ampicillin/sulbactam. This report of treatment failure due to ciprofloxacin-resistant Streptococcus pneumoniae shows that fluoroquinolones should be avoided when treating patients who have recently received this class of antibiotics. 相似文献
9.
H. Lode P. Magyar J. F. Muir U. Loos K. Kleutgens 《Clinical microbiology and infection》2004,10(6):512-520
A double-blind, double-dummy, multicentre, multinational, parallel-group study was designed to establish proof of equivalence between oral gatifloxacin and oral co-amoxiclav in the treatment of 462 patients with mild-to-moderate community-acquired pneumonia. Eligible patients were randomised equally to either gatifloxacin 400 mg once-daily plus matching placebo for 5-10 days, or amoxycillin 500 mg + clavulanic acid 125 mg three-times-daily for 5-10 days. The primary efficacy endpoint was clinical response (clinical cure plus improvement) at the end of treatment. Overall, a successful clinical response was achieved in 86.8% of gatifloxacin-treated patients, compared with 81.6% of those receiving co-amoxiclav, while corresponding rates of bacteriological efficacy (eradication plus presumed eradication) were 83.1% and 78.7%, respectively. The safety and tolerability profile of gatifloxacin was comparable to that of co-amoxiclav, with adverse gastrointestinal events, e.g., diarrhoea and nausea, being the most common treatment-related adverse events in both groups. The study showed no evidence of gatifloxacin-induced phototoxicity, musculoskeletal disorders, or hepatic and renal problems. Overall, this study showed that gatifloxacin was equivalent clinically to a standard course of co-amoxiclav in patients with community-acquired pneumonia, and that gatifloxacin was safe and well-tolerated. 相似文献
10.
Epstein-Barr viral load as a marker of lymphoma in AIDS patients 总被引:5,自引:0,他引:5
Fan H Kim SC Chima CO Israel BF Lawless KM Eagan PA Elmore S Moore DT Schichman SA Swinnen LJ Gulley ML 《Journal of medical virology》2005,75(1):59-69
Epstein-Barr virus (EBV) is implicated in the pathogenesis of acquired immunodeficiency syndrome (AIDS) lymphoma, and viral DNA is present within the malignant cells in about half of affected patients. We examined the extent to which EBV viral load is elevated in the plasma of AIDS lymphoma patients compared to AIDS patients with opportunistic infections. Sixty-one AIDS patients were studied including 35 with lymphoma (24 non-Hodgkin, six Hodgkin, and five brain lymphoma) and 26 with various opportunistic infections. In situ hybridization revealed EBV encoded RNA (EBER) expression in the malignant cells of 17/28 AIDS lymphomas (61%). In 232 serial plasma samples from 35 lymphoma patients and in 128 samples from AIDS controls, EBV viral load was assayed by quantitative-polymerase chain reaction (Q-PCR) using a TaqMan probe targeting the BamH1W sequence. EBV was detected in plasma from all 17 EBER-positive AIDS lymphoma patients, with viral loads ranging from 34 to 1,500,000 copies per ml (median 3,210). Viral load usually fell rapidly upon initiation of lymphoma therapy and remained undetectable except in two patients with persistent tumor. In 11 AIDS patients, whose lymphoma lacked EBER expression, and in 26 control patients without lymphoma, levels of EBV in plasma were usually low or undetectable (range 0-1,995 and 0-2,409, median 0 and 0, respectively). There was no association between EBV viral load and human immunodeficiency virus (HIV) load or CD4 count. In conclusion, EBV viral load shows promise as a tool to assist in diagnosis and management of EBV-related lymphoma patients. 相似文献